Product Search Results

156 products match your search.
Acetylcysteine Injection 200 mg/mL (6g/30mL)

Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS

Adapalene Cream, 0.1%
Generic to: Differin® Cream
Alogliptin and Metformin HCl Tablets, 12.5 mg/500 mg; 12.5 mg/1000 mg
Authorized Generic to: Kazano®
Alogliptin and Pioglitazone Tablets, 12.5 mg/15 mg; 12.5 mg/30 mg; 12.5 mg/45 mg; 25 mg/15 mg; 25 mg/30 mg; 25 mg/45 mg
Authorized Generic to: Oseni®
Alogliptin Tablets, 6.25 mg; 12.5 mg; 25 mg
Authorized Generic to: Nesina®
Amiloride HCI Tablets, USP 5 mg
Generic to: Midamor®
Ammonium Lactate Cream, 12%
Generic to: Lac-Hydrin®
Ammonium Lactate Lotion, 12%
Compare to: Lac-Hydrin®
Azelastine HCl Nasal Solution (Nasal Spray), 0.15%
Generic to: Astepro®
Bacitracin Ophthalmic Ointment USP

Belladonna and Opium Suppositories C-II

Betamethasone Dipropionate Cream, USP (Augmented), 0.05%
Generic to: Diprolene AF®
Betamethasone Dipropionate Lotion USP, 0.05%
Generic to: Diprosone®
Betamethasone Valerate Foam, 0.12%
Generic to: Luxiq®
Bromocriptine Mesylate Tablets, USP 2.5 mg
Generic to: Parlodel®
Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Syrup
Generic to: Bromfed® DM
Calcipotriene and Betamethasone Dipropionate Ointment, 0.005%/0.064%
Generic to: Taclonex®
Calcitriol Ointment, 3 mcg/g
Generic to: Vectical® Ointment
Calcium Acetate Tablets, USP
Generic to: Eliphos®
Cetirizine Hydrochloride Syrup, 1mg/mL
Generic to: Zyrtec® Syrup
Ciclopirox Gel, 0.77%
Generic to: LOPROX®
Ciclopirox Olamine Cream USP, 0.77%
Generic to: Loprox®
Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion)
Generic to: Loprox® Topical Suspension
Ciclopirox Shampoo, 1%
Generic to: Loprox®
Ciclopirox Topical Solution, 8%
Generic to: Penlac®
Clindamycin and Benzoyl Peroxide Topical Gel, 1%/5%
Generic to: Benzaclin®
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%
Generic to: DUAC® Gel
Clindamycin Phosphate Foam, 1%
Generic to: Evoclin®
Clindamycin Phosphate Topical Solution USP, 1%
Generic to: Cleocin-T®
Clindamycin Phosphate Topical Solution USP, 1% (Pledgets)
Generic to: Cleocin-T®
Clobetasol Propionate Foam (Emollient Formulation) 0.05%
Generic to: Olux-E®
Clobetasol Propionate Foam, 0.05%
Generic to: Olux®
Clobetasol Propionate Gel, 0.05%
Generic to: Temovate®
Clobetasol Propionate Lotion 0.05%

Clobetasol Propionate Shampoo, 0.05%
Generic to: Clobex® Shampoo
Clobetasol Propionate Topical Solution USP, 0.05% Spray
Generic to: Clobex® Spray
Clotrimazole Lozenges
Generic to: Mycelex® Troches
COLOCORT® Hydrocortisone Rectal Suspension USP (Retention)
Generic to: Cortenema®
COMPro® Prochlorperazine Suppositories, USP 25 mg

Cyclosporine Injection, USP 250 mg/5 mL (50 mg/mL)

Desonide Cream, 0.05%
Generic to: Tridesilon®
Desonide Ointment, 0.05%
Generic to: Tridesilon®
Desoximetasone Ointment USP, 0.25%
Generic to: Topicort®
Desoximetasone Cream USP, 0.25%
Generic to: Topicort®
Dihydroergotamine Mesylate Injection, USP 1 mg/mL
Generic to: D.H.E. 45®
Econazole Nitrate Cream, 1%
Generic to: Spectazole®
Entocort® EC

Ery 2% Pads
Generic to: Erycette®
Erythromycin Ophthalmic Ointment USP

Erythromycin Topical Gel USP, 2%
Generic to: Erygel®
Erythromycin Topical Solution USP, 2%

Estradiol Valerate Injection, USP 100 mg/5 mL
Generic to: Delestrogen®
Estradiol Valerate Injection, USP 200 mg/5 mL
Generic to: Delestrogen®
Famotidine for Oral Suspension
Generic to: PEPCID® ORAL SUSPENSION
Fenofibrate Tablets 145 mg
Generic to: TriCor®
Fenofibrate Tablets 48 mg
Generic to: TriCor®
Flavoxate HCl Tablets 100 mg
Generic to: URISPAS®
Fluocinonide Cream USP, 0.1%
Generic to: Vanos®
Flurandrenolide Lotion USP, 0.05%
Generic to: Cordran®
Fluticasone Propionate Cream, 0.05%
Generic to: Cutivate®
Fluticasone Propionate Lotion, 0.05%
Generic to: Cutivate®
Fluticasone Propionate Ointment, 0.005%
Generic to: Cutivate®
Gentamicin Sulfate Cream USP, 0.1%
Generic to: Garamycin®
Gentamicin Sulfate Ointment USP, 0.1%
Generic to: Garamycin®
Gentamicin Sulfate Ophthalmic Ointment USP, 0.3%

Halobetasol Propionate Cream, 0.05%
Generic to: Ultravate®
Halobetasol Propionate Ointment, 0.05%
Generic to: Ultravate®
Hydrocodone Bitartrate Chlorpheniramine Maleate and Pseudoephedrine HCl Oral Solution 5 mg/4 mg/ 60 mg per 5 mL CII
Generic to: ZUTRIPRO®
Hydrocortisone 1% - Iodoquinol 1% Cream
Compare to the Active Ingredients of: Vytone®
Hydrocortisone Acetate 1% Pramoxine HCl 1% Cream
Authorized Generic to: Analpram HC® Cream 1%
Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream
Authorized Generic to: Analpram HC® Cream 2.5%
Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream
Authorized Generic to: Pramosone® Cream 2.5%
Hydrocortisone Acetate Suppositories 25 mg

Hydrocortisone Acetate Suppositories 30 mg

Hydrocortisone Acetate, USP Micronized Powder

Hydrocortisone Cream USP, 2.5%
Generic to: Hytone®
Hydrocortisone Lotion USP, 2.5%
Generic to: Hytone®
Hydrocortisone Ointment USP, 2.5%
Generic to: Hytone®
Hydrocortisone Valerate Cream USP, 0.2%
Generic to: Westcort®
Hydrocortisone, USP Micronized Powder

HYDROmorphone HCl Extended-Release Tablets 12 mg
Generic to: EXALGO®
HYDROmorphone HCl Extended-Release Tablets 16 mg
Generic to: EXALGO®
HYDROmorphone HCl Extended-Release Tablets 8 mg
Generic to: EXALGO®
HYDROmorphone Hydrochloride 3 mg Suppositories CII

Hydroquinone Time Release Cream 4%
Compare to the Active Ingredient of: EpiQuin® Micro
Hydroquinone USP, 4% Skin Bleaching Cream
Compare to the Active Ingredient of: Eldoquin Forte®
Ibuprofen Oral Suspension USP 100mg/5mL
Generic to: Motrin®
Imiquimod Cream, 5%
Generic to: Aldara® Cream 5%
Ketoconazole Foam, 2%
Generic to: Extina®
Ketoconazole Shampoo, 2%
Generic to: Nizoral®
Kionex® Sodium Polystyrene Sulfonate Suspension, USP
Generic to: SPS® SUSPENSION
Levocetirizine Dihydrochloride Oral Solution 2.5 mg/5 mL (0.5 mg/mL)
Generic to: Xyzal®
Levocetirizine Dihydrochloride Tablets 5mg
Generic to: Xyzal®
Liothyronine Sodium Tablets, USP
Generic to: CYTOMEL®
Mesalamine Rectal Suspension USP (Enema), 4 g/60mL KIT
Generic to: Rowasa® Kit
Mesalamine Rectal Suspension USP (Enema), 4 grams/60 mL
Generic to: Rowasa®
Methazolamide Tablets, USP 25 mg
Generic to: Neptazane®
Methazolamide Tablets, USP 50 mg
Generic to: Neptazane®
Midazolam HCl Syrup 2 mg/mL CIV

Mometasone Furoate Cream USP, 0.1%
Generic to: Elocon®
Mometasone Furoate Ointment USP, 0.1%
Generic to: Elocon®
Mometasone Furoate Topical Solution USP, 0.1%
Generic to: Elocon®
Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL) C-II

Morphine Sulfate Suppositories C-II

Mupirocin Ointment USP, 2%
Generic to: Bactroban®
Naratriptan Tablets, USP 2.5 mg
Generic to: AMERGE®
Neo-Polycin® HC neomycin and polymyxin B sulfates, bacitracin zinc, and hydrocortisone acetate Ophthalmic Ointment USP

Neo-Polycin® neomycin and polymyxin B sulfates and bacitracin zinc Ophthalmic Ointment USP
Generic to: (Bausch and Lomb) Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment USP
Generic to: Maxitrol®
Nitroglycerin Lingual Spray
Generic to: Nitrolingual®
Nystatin Cream USP, 100,000 U/G
Generic to: Mycostatin®
Nystatin Ointment USP, 100,000 U/G
Generic to: Mycostatin®
NYSTOP® Nystatin Topical Powder, USP
Compare to: MYCOSTATIN®
Olopatadine Hydrochloride Nasal Spray, 665 mcg
Generic to: Patanase®
Permethrin Cream, 5%
Generic to: Elimite®
Podocon-25® (25% Podophyllin in benzoin tincture)

Podofilox Topical Solution 0.5%
Generic to: Condylox®
Polycin® bacitracin zinc and polymyxin B sulfate Ophthalmic Ointment USP
Generic to: (Bausch and Lomb) Bacitracin Zinc and Polymyxin B Sulfate
Polyethylene Glycol 3350, NF Powder For Oral Solution

Potassium Chloride Extended-Release Capsules USP (600 mg) 8 mEq K

Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K

Potassium Chloride Extended-release Tablets, USP 10 mEq (750 mg)
Generic to: Klor-Con®
Potassium Chloride Extended-release Tablets, USP 8 mEq (600 mg)
Generic to: Klor-Con®
Promethazine Hydrochloride Suppositories USP, 12.5 mg
Generic to: Phenergan®
Promethazine Hydrochloride Suppositories USP, 25 mg
Generic to: Phenergan®
Repaglinide Tablets, USP 0.5 mg
Generic to: Prandin®
Repaglinide Tablets, USP 1 mg
Generic to: Prandin®
Repaglinide Tablets, USP 2 mg
Generic to: Prandin®
Salicylic Acid Cream, 6%
Compare to the Active Ingredient of: Salex®
Salicylic Acid Lotion, 6%
Compare to the Active Ingredient of: Salex®
Salicylic Acid Shampoo, 6% (w/w)
Compare to the Active Ingredient of: Salex®
SEB-Prev™ Wash (Sodium Sulfacetamide 10%)
Compare to the Active Ingredient of: Ovace®
Selenium Sulfide Topical Suspension USP, 2.5% (Lotion)
Generic to: Selsun® Rx
Sodium Polystyrene Sulfonate Suspension, USP 15 g/60 mL

Sulfacetamide Sodium Ophthalmic Ointment USP, 10%
Generic to: Cetamide®
Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Generic to: Klaron®
Tacrolimus Ointment 0.03%
Generic to: Protopic® Ointment 0.03%
Tacrolimus Ointment 0.1%
Generic to: Protopic® Ointment 0.1%
Terconazole Vaginal Suppositories, 80 mg
Generic to: Terazol® 3
Testosterone Cypionate Injection, USP 200 mg/mL C-III
Generic to: Depo® Testosterone
Testosterone Cypionate Injection, USP 2000 mg/10 mL (200 mg/mL) C-III
Generic to: Depo® Testosterone
Testosterone Gel 12.5 mg of testosterone per pump actuation CIII
Generic to: Androgel® 1%
Testosterone Gel 25 mg of testosterone per packet CIII
Generic to: Androgel® 1%
Testosterone Gel 50 mg of testosterone per packet CIII
Generic to: Androgel® 1%
Tretinoin Cream, USP 0.025%; 0.05%; 0.1%
Generic to: Retin-A®
Tretinoin Gel, USP 0.01%; 0.025%
Generic to: Retin-A®
Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g
Generic to: Kenalog® Spray
Triamcinolone Acetonide Cream USP, 0.025%
Generic to: Kenalog®
Triamcinolone Acetonide Cream USP, 0.1%
Generic to: Kenalog®
Triamcinolone Acetonide Cream USP, 0.5%
Generic to: Kenalog®
Triamcinolone Acetonide Ointment USP, 0.025%
Generic to: Kenalog®
Triamcinolone Acetonide Ointment USP, 0.1%
Generic to: Aristocort®
Triamcinolone Acetonide Ointment USP, 0.5%
Generic to: Aristocort®
Trospium Chloride Extended-Release Capsules 60 mg
Generic to: Sanctura XR®
Trospium Chloride Tablets 20 mg
Generic to: Sanctura®
Important Safety Information
  • Alogliptin is contraindicated in patients with a history of serious hypersensitivity reaction to alogliptin-containing products such as anaphylaxis, angioedema, or severe cutaneous adverse reactions.
  • Acute pancreatitis: There have been postmarketing reports of acute pancreatitis. If pancreatitis is suspected, promptly discontinue Alogliptin.
  • Hypersensitivity: There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Alogliptin such as anaphylaxis, angioedema or severe cutaneous adverse reactions. In such cases, promptly discontinue Alogliptin, assess for other potential causes, institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes. Use caution in a patient with a history of angioedema with another DPP-4i because it is unknown whether such patients will be predisposed to angioedema.
  • Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal. Causality cannot be excluded. Baseline liver test panel is recommended. If liver injury is detected, promptly interrupt Alogliptin and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart Alogliptin if liver injury is confirmed and no alternative etiology can be found.
  • Hypoglycemia: Insulin and insulin secretagogues are known to cause hypoglycemia. A lower dose of the insulin or insulin secretagogue may be required to minimize the risk when used in combination with Alogliptin.
  • Arthralgia: Severe and disabling arthralgia has been reported in patients taking DPP-4 inhibitors. Consider as a possible cause for severe joint pain and discontinue drug if appropriate.
  • Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Alogliptin or any other anti-diabetic drug.
  • Most common adverse reactions (4% of patients treated with Alogliptin 25 mg and more frequently than in patients who received placebo) were nasopharyngitis (4.4%), headache (4.2%), and upper respiratory tract infection (4.2%).

Patients taking Alogliptin should contact their health care professionals right away if they develop signs and symptoms of heart failure such as:

  • Unusual shortness of breath during daily activities
  • Trouble breathing when lying down
  • Tiredness, weakness, or fatigue
  • Weight gain with swelling in the ankles, feet, legs, or stomach Patients should not stop taking their medicine without first talking to their health care professionals.

Patients should not stop taking their medicine without first talking to their health care professionals.

Indication

Alogliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Alogliptin is not for treatment of type 1 diabetes or diabetic ketoacidosis.

Please see Full Prescribing Information, including Medication Guide for Alogliptin.


©2016 Perrigo Company, plc

Cookie Policy

By using our site you consent to the use of cookies in accordance with the terms of our privacy policy.

Hide this message
Perrigo on Facebook Perrigo on Twitter Perrigo on YouTube Perrigo on LinkedIn Perrigo RSS